Qube Research & Technologies LTD Veracyte, Inc. Transaction History
Qube Research & Technologies LTD
- $62.3 Billion
- Q2 2024
A detailed history of Qube Research & Technologies LTD transactions in Veracyte, Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 92,970 shares of VCYT stock, worth $3.28 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
92,970
Previous 342,417
72.85%
Holding current value
$3.28 Million
Previous $7.59 Million
73.45%
% of portfolio
0.0%
Previous 0.01%
Shares
10 transactions
Others Institutions Holding VCYT
# of Institutions
254Shares Held
82.1MCall Options Held
42.3KPut Options Held
18.2K-
Black Rock Inc. New York, NY7.79MShares$275 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.5MShares$264 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA6.88MShares$242 Million0.03% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl6.81MShares$240 Million1.34% of portfolio
-
Dimensional Fund Advisors LP Austin, TX3.46MShares$122 Million0.02% of portfolio
About VERACYTE, INC.
- Ticker VCYT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,575,904
- Market Cap $2.52B
- Description
- Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...